vs

Side-by-side financial comparison of Ceribell, Inc. (CBLL) and Namib Minerals (NAMM). Click either name above to swap in a different company.

Namib Minerals is the larger business by last-quarter revenue ($41.9M vs $24.8M, roughly 1.7× Ceribell, Inc.). Namib Minerals produced more free cash flow last quarter ($7.4M vs $-11.0M).

Ceribell, Inc. develops and commercializes innovative portable neurodiagnostic medical devices, focused on rapid non-invasive electroencephalogram (EEG) solutions for seizure detection. Its core products serve hospital emergency departments, intensive care units, and long-term care facilities, with primary markets across North America and ongoing global expansion efforts.

Namib Minerals is a Namibia-based natural resources firm focused on exploration, development and extraction of high-demand mineral deposits including uranium, copper and lithium. It operates across licensed southern African sites, supplying raw materials to global clean energy, construction and electronics manufacturing sectors.

CBLL vs NAMM — Head-to-Head

Bigger by revenue
NAMM
NAMM
1.7× larger
NAMM
$41.9M
$24.8M
CBLL
More free cash flow
NAMM
NAMM
$18.3M more FCF
NAMM
$7.4M
$-11.0M
CBLL

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
CBLL
CBLL
NAMM
NAMM
Revenue
$24.8M
$41.9M
Net Profit
$-13.5M
Gross Margin
87.3%
45.7%
Operating Margin
-58.9%
29.8%
Net Margin
-54.6%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBLL
CBLL
NAMM
NAMM
Q4 25
$24.8M
Q3 25
$22.6M
Q2 25
$21.2M
$41.9M
Q1 25
$20.5M
Q3 24
$17.2M
Net Profit
CBLL
CBLL
NAMM
NAMM
Q4 25
$-13.5M
Q3 25
$-13.5M
Q2 25
$-13.6M
Q1 25
$-12.8M
Q3 24
$-10.4M
Gross Margin
CBLL
CBLL
NAMM
NAMM
Q4 25
87.3%
Q3 25
88.3%
Q2 25
88.1%
45.7%
Q1 25
87.9%
Q3 24
87.3%
Operating Margin
CBLL
CBLL
NAMM
NAMM
Q4 25
-58.9%
Q3 25
-64.8%
Q2 25
-70.5%
29.8%
Q1 25
-69.3%
Q3 24
-57.8%
Net Margin
CBLL
CBLL
NAMM
NAMM
Q4 25
-54.6%
Q3 25
-59.6%
Q2 25
-64.4%
Q1 25
-62.4%
Q3 24
-60.6%
EPS (diluted)
CBLL
CBLL
NAMM
NAMM
Q4 25
$-0.35
Q3 25
$-0.37
Q2 25
$-0.38
Q1 25
$-0.36
Q3 24
$-1.85

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBLL
CBLL
NAMM
NAMM
Cash + ST InvestmentsLiquidity on hand
$159.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$155.3M
Total Assets
$195.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBLL
CBLL
NAMM
NAMM
Q4 25
$159.3M
Q3 25
$168.5M
Q2 25
$177.4M
Q1 25
$182.7M
Q3 24
$14.1M
Stockholders' Equity
CBLL
CBLL
NAMM
NAMM
Q4 25
$155.3M
Q3 25
$164.1M
Q2 25
$172.2M
Q1 25
$180.9M
Q3 24
$-136.0M
Total Assets
CBLL
CBLL
NAMM
NAMM
Q4 25
$195.8M
Q3 25
$199.5M
Q2 25
$207.7M
Q1 25
$213.5M
Q3 24
$47.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBLL
CBLL
NAMM
NAMM
Operating Cash FlowLast quarter
$-10.8M
$11.4M
Free Cash FlowOCF − Capex
$-11.0M
$7.4M
FCF MarginFCF / Revenue
-44.2%
17.6%
Capex IntensityCapex / Revenue
0.7%
9.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBLL
CBLL
NAMM
NAMM
Q4 25
$-10.8M
Q3 25
$-11.1M
Q2 25
$-7.5M
$11.4M
Q1 25
$-11.4M
Q3 24
Free Cash Flow
CBLL
CBLL
NAMM
NAMM
Q4 25
$-11.0M
Q3 25
$-11.5M
Q2 25
$-7.6M
$7.4M
Q1 25
$-11.6M
Q3 24
FCF Margin
CBLL
CBLL
NAMM
NAMM
Q4 25
-44.2%
Q3 25
-50.8%
Q2 25
-35.9%
17.6%
Q1 25
-56.4%
Q3 24
Capex Intensity
CBLL
CBLL
NAMM
NAMM
Q4 25
0.7%
Q3 25
1.6%
Q2 25
0.3%
9.6%
Q1 25
0.7%
Q3 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBLL
CBLL

Products$18.8M76%
Subscription$6.0M24%

NAMM
NAMM

Segment breakdown not available.

Related Comparisons